|
SE9603726D0
(sv)
*
|
1996-10-11 |
1996-10-11 |
Astra Ab |
Novel compounds
|
|
US6410328B1
(en)
*
|
1998-02-03 |
2002-06-25 |
Protiva Biotherapeutics Inc. |
Sensitizing cells to compounds using lipid-mediated gene and compound delivery
|
|
WO1999039741A2
(en)
*
|
1998-02-03 |
1999-08-12 |
Inex Pharmaceuticals Corporation |
Systemic delivery of serum stable plasmid lipid particles for cancer therapy
|
|
IL131887A0
(en)
*
|
1999-09-14 |
2001-03-19 |
Dpharm Ltd |
Phospholipid prodrugs of anti-proliferative drugs
|
|
KR20020073494A
(ko)
*
|
1999-12-29 |
2002-09-26 |
더 리전트 오브 더 유니버시티 오브 캘리포니아 |
약물내성 인체 면역결핍 바이러스 감염의 치료
|
|
EP1460082A1
(en)
*
|
2003-03-19 |
2004-09-22 |
Heidelberg Pharma Holding GmbH |
Phospholipid esters of clofarabine derivatives
|
|
DE602005012155D1
(de)
*
|
2004-11-03 |
2009-02-12 |
Liplasome Pharma As |
Arzneimittelabgabesysteme auf lipidbasis mit unnatürlichen phospholipase-a2-abbaubaren lipid-derivaten und ihre therapeutische verwendung
|
|
CA2586363A1
(en)
|
2004-11-15 |
2006-05-26 |
Ceptyr, Inc. |
Protein tyrosine phosphatase inhibitors and methods of use thereof
|
|
ES2401285T3
(es)
|
2004-12-16 |
2013-04-18 |
The Regents Of The University Of California |
Fármacos con el pulmón como diana
|
|
EP2004236A2
(en)
*
|
2006-03-23 |
2008-12-24 |
Liplasome Pharma A/S |
Lipid based drug delivery systems comprising phospholipase a2 degradable lipids that perform an intramolecular cyclization reaction upon hydrolysis
|
|
US7749983B2
(en)
*
|
2006-05-03 |
2010-07-06 |
Chimerix, Inc. |
Metabolically stable alkoxyalkyl esters of antiviral or antiproliferative phosphonates, nucleoside phosphonates and nucleoside phosphates
|
|
US8741966B2
(en)
*
|
2007-11-09 |
2014-06-03 |
Pronova Biopharma Norge As |
Lipid compounds for use in cosmetic products, as food supplement or as a medicament
|
|
EP2070938A1
(en)
*
|
2007-12-13 |
2009-06-17 |
Heidelberg Pharma AG |
Clofarabine dietherphospholipid derivatives
|
|
EP2234623A4
(en)
*
|
2007-12-27 |
2012-03-28 |
Epiphany Biosciences |
ANTIVIRAL CONNECTIONS
|
|
EP2278963A4
(en)
*
|
2008-01-16 |
2014-09-17 |
Anwar Rayan |
TAXOL DERIVATIVES AND CLOSELY RELATED COMPOUNDS
|
|
EP2147910A1
(en)
*
|
2008-07-15 |
2010-01-27 |
Pronova BioPharma Norge AS |
Novel lipid compounds
|
|
JP5843755B2
(ja)
|
2009-05-08 |
2016-01-13 |
プロノヴァ・バイオファーマ・ノルゲ・アーエスＰｒｏｎｏｖａ ＢｉｏＰｈａｒｍａ Ｎｏｒｇｅ ＡＳ |
心血管性、代謝性および炎症性疾患領域に関する疾患の処置のための多価不飽和脂肪酸
|
|
US8884027B2
(en)
|
2010-10-22 |
2014-11-11 |
University Of Rochester |
Melampomagnolide B derivatives as antileukemic and cytotoxic agents
|
|
NZ610705A
(en)
|
2010-11-05 |
2014-10-31 |
Pronova Biopharma Norge As |
Methods of treatment using lipid compounds
|
|
AU2014222389B2
(en)
|
2013-02-28 |
2018-11-29 |
Pronova Biopharma Norge As |
A composition comprising a lipid compound, a triglyceride, and a surfactant, and methods of using the same
|
|
SMT201800538T1
(it)
|
2013-03-15 |
2019-01-11 |
Univ California |
Diesteri di fosfonato nucleosidico aciclico
|
|
DK3116511T3
(da)
|
2014-03-14 |
2020-11-23 |
Alltech Inc |
Sammensætninger af selenoorganiske forbindelser og fremgangsmåder til anvendelse deraf
|
|
HRP20220651T1
(hr)
|
2014-09-15 |
2022-08-19 |
The Regents Of The University Of California |
Nukleotidni analozi
|
|
ES2855299T3
(es)
|
2014-11-26 |
2021-09-23 |
Vascular Biogenics Ltd |
Lípidos oxidados y tratamiento o prevención de la fibrosis
|
|
US9771385B2
(en)
*
|
2014-11-26 |
2017-09-26 |
Vascular Biogenics Ltd. |
Oxidized lipids
|
|
GEP20217282B
(en)
|
2015-03-06 |
2021-08-10 |
Atea Pharmaceuticals Inc |
β-D-2'-DEOXY-2'α-FLUORO-2'-β-C-SUBSTITUTED-2-MODIFIED-N6-SUBSTITUTED PURINE NUCLEOTIDES FOR HCV TREATMENT
|
|
US20180104201A1
(en)
|
2015-04-28 |
2018-04-19 |
Pronova Biopharma Norge As |
Use of structurally enhanced fatty acids containing sulphur for preventing and or treating non alcoholic steatohepatitis
|
|
WO2017048252A1
(en)
|
2015-09-15 |
2017-03-23 |
Alltech, Inc. |
Compositions of selenoorganic compounds and methods of use thereof
|
|
US10377782B2
(en)
|
2015-09-15 |
2019-08-13 |
The Regents Of The University Of California |
Nucleotide analogs
|
|
WO2018013937A1
(en)
|
2016-07-14 |
2018-01-18 |
Atea Pharmaceuticals, Inc. |
Beta-d-2'-deoxy-2'-alpha-fluoro-2'-beta-c-substituted-4'-fluoro-n6-substituted-6-amino-2-substituted purine nucleotides for the treatment of hepatitis c virus infection
|
|
PT3512863T
(pt)
|
2016-09-07 |
2022-03-09 |
Atea Pharmaceuticals Inc |
Nucleótidos de purina 2'-substituídos-n6-substituídos para tratamento de vírus de rna
|
|
PT3720431T
(pt)
|
2017-12-06 |
2024-12-05 |
Basf As |
Derivados de ácidos gordos para o tratamento da esteato-hepatite não alcoólica
|
|
CA3131977C
(en)
*
|
2019-03-22 |
2022-04-26 |
Integrated Nanotherapeutics Inc. |
Lipid conjugate prepared from scaffold moiety
|
|
CA3152013A1
(en)
|
2019-08-22 |
2021-02-25 |
Emory University |
Nucleoside prodrugs and uses related thereto
|
|
WO2021173713A1
(en)
|
2020-02-27 |
2021-09-02 |
Atea Pharmaceuticals, Inc. |
Highly active compounds against covid-19
|
|
US10874687B1
(en)
|
2020-02-27 |
2020-12-29 |
Atea Pharmaceuticals, Inc. |
Highly active compounds against COVID-19
|
|
MX2023002233A
(es)
|
2020-08-24 |
2023-03-15 |
Gilead Sciences Inc |
Compuestos fosfolipidos y usos de estos.
|
|
TWI811812B
(zh)
|
2020-10-16 |
2023-08-11 |
美商基利科學股份有限公司 |
磷脂化合物及其用途
|
|
JP2025526212A
(ja)
|
2022-07-21 |
2025-08-13 |
アンティバ バイオサイエンシズ インコーポレイテッド |
Ｈｐｖ感染症及びｈｐｖ誘発性新生物の治療用の組成物及び剤形
|